Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SVV | Common Stock | Options Exercise | $7.05K | +5K | $1.41* | 5K | Feb 12, 2024 | Direct | ||
transaction | SVV | Common Stock | Options Exercise | $7.05K | +5K | +100% | $1.41* | 10K | Feb 12, 2024 | Direct | |
transaction | SVV | Common Stock | Sale | -$200K | -10K | -100% | $20.00 | 0 | Feb 12, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SVV | Option (Right to Purchase) | Options Exercise | $0 | -5K | -1.12% | $0.00 | 440K | Feb 12, 2024 | Common Stock | 5K | $1.41 | Direct | F2, F3, F4 |
transaction | SVV | Option (Right to Purchase) | Options Exercise | $0 | -5K | -0.83% | $0.00 | 601K | Feb 12, 2024 | Common Stock | 5K | $1.41 | Direct | F2, F5, F6 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Id | Content |
---|---|
F1 | The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on September 15, 2023. |
F2 | Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. |
F3 | The June 12, 2019 stock option grant vests in substantially equal annual installments over five years starting March 28, 2020, until fully vested on March 28, 2024. |
F4 | Approximately 40% represents time-based options with a vesting schedule in substantially equal annual installments over five years starting March 28, 2020, and approximately 60% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance. |
F5 | The November 1, 2019 stock option grant vests in substantially equal annual installments over five years starting November 1, 2020, until fully vested on November 1, 2024. |
F6 | Approximately 40% represents time-based options with a vesting schedule in substantially equal annual installments over five years starting November 1, 2020, and approximately 60% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance. |
President and Chief Operating Officer